| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0008 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |